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7-Azidoketanserin, a potent photoaflinity probe for serotonin-S, receptors was shown to irreversibly pho- 
toinactivate histamine-H, receptors as well. The photolabelling of Hi-receptors could be prevented by sever- 
al selective histamine-H, antagonists. In guinea pig cere~llum. a brain area that is highly enriched in H,- 
receptors, photola~lling could be directed exclusively to these receptors by adding a high concentration 
of pipamperone, which selectively blocks serotonin-S, receptors. In rat pre-frontal corex, a region that is 
enriched in serotonin-S, receptors, pyrilamine was used to block Hi-receptors, thereby directing the photo- 
labelling exclusively to &-receptors. 
1. INTRODUCTION serotonin receptors, but only few histamine recep- 
tors, are found [2,8]. 
Serotonin-Sz receptors were identified in recep- To get a better understanding of the molecular 
tor binding studies using [3H]spiperone or mechanisms of serotonin and histamine receptors, 
[3H]ketanserin as the ligand [ 1,2]. Their purification and molecular characterization of the 
physiological role in the antagonism of several receptor protein is a prerequisite. Photoaffinity 
serotonergic effects as measured both in vitro and labelling should provide new possibilities to 
in vivo has been thoroughly investigated [1,3] _ achieve this goal. 
Histamine-HI receptors were first identified in in 
vitro binding studies using the guinea pig ileum 141. 
Later on, histamine-Hi receptors were demon- 
strated in the brain and in several peripheral tissues 
using [3H]pyrilamine, a selective Hr-antagonist 
[5,6]. In the periphery, several roles for Hr-re- 
ceptors have been identified. In the brain, 
however, the precise role of Hr-receptors is not 
clear although they seem to be involved in seda- 
tion, one of the most prominent effects of 
histamine antagonists [7]. 
Recently we reported the use of a new photoaf- 
finity probe, ‘I-azidoketanserin (7-azido-3-[2-[4- 
(4 - fluorobenzoyl) - 1 - piperidinyllethyl] -2,4 - (III, 
3li)-quinazolinedione) for irreversible labelling of 
brain serotonin-Sjz receptors [9]. We now provide 
evidence that this new photoaffinity ligand can be 
used to irreversibly label brain histamine-H* recep- 
tors as well. Differential labelling of either of both 
receptor systems can be achieved using a combina- 
tion of different tissues and selective displacers. 
The regional distribution of serotonin-Sz and 
histamine-H1 receptors markedly differs in the rat 
and guinea pig brain. The guinea pig cerebellum is 
highly enriched in histamine receptors but is prac- 
tically devoid of serotonin receptors. By contrast, 
in the rat pre-frontal cortex a large number of 
2. MATERIALS AND METHODS 
2.1. Drugs and chemicals 
7-Azidoketanserin was synthesized from the cor- 
responding amino-derivative of ketanserin by 
Histamine-~~ receptor 
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diazotation and subsequent reaction with sodium sion). Non-specific binding was determined in the 
azide. The complete synthesis and characterization presence of 1 yM astemizole [lo]. Following the 
of this new compound will be described elsewhere binding assays, filters were equilibrated with 8 ml 
(unpublished). The structure of the compound is Insta-Gel II (Packard) and counted in a Packard 
depicted in fig.1. Tri-Carb 460 liquid scintillation counter. 
[3H]Spiperone (23.4 Ci/mmol) and [3H]pyril- 
amine (24.1 Ci/mmol) were supplied by New 
England Nuclear (FRG). Drugs were kindly pro- 
vided by their own companies. Histamine and 
serotonin were from Janssen Chimica, bufotenine 
was from Serva (Heidelberg, FRG). All common 
reagents were of the highest purity available and 
were obtained from different suppliers. 
Serotonin-Sz receptors were assayed with 
[3H]spiperone. Aliquots (2 ml) of the membrane 
suspension in buffer B were incubated with 2 nM 
of the [3H]ligand for 15 min at 37°C. Filtration 
and counting were performed as described above. 
Non-specific binding was determined using 2 PM 
methysergide [2]. 
2.2. Tissue preparation 
Female pirbright guinea pigs and female Wistar 
rats were killed by decapitation and their brains 
were rapidly removed. Pre-frontal cortex and 
cerebellum were dissected and immediately 
homogenized in 10 vols of 0.25 M sucrose. Subse- 
quently an (M + L + P)-fraction was prepared as 
in [2]. The final washed pellets were suspended 
either in buffer A (50 mM Tris-HCl, pH 7.7) or in 
buffer B (50 mM Tris-HCl, pH 7.6, containing 
120 mM NaCl, 5 mM KCI, 2 mM CaCl2, 1 mM 
MgCl2, 0.1% ascorbic acid and 10pM pargyline) 
at a final dilution of l/100, w/v (original wet 
weight of tissue per volume). 
2.3. Binding assays 
For the assay of histamine-HI receptors, ali- 
quots (2 ml) of the membrane preparations in buf- 
fer B were incubate with 1 nM [3H]lpyrilamine for 
30 min at 25°C in the presence or absence of other 
drugs. Free and bound ligand were separated by 
rapid filtration through glass-fibre filters (What- 
man GF/B) using a 40-well filtration manifold 
(Multividor, Janssen Scientific Instruments Divi- 
‘I-AZIDOKETANSERIN 
Fig. 1. Chemical structure of 7-azidoketanserin. 
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2.4. Photolabelling 
Aliquots of the membrane preparations in buf- 
fer A were preincubated for 15 min at 37°C with 
different concentrations of 7-azidoketanserin in 
the presence or absence of other drugs. The 
samples were subsequently irradiated for 10 min 
with long-wavelength UV light (366 mm) in quartz 
test tubes at an average distance of 4 cm from a 
Camag Universal UV lamp (Camag, Muttenz, 
Switzerland). Following photolysis, the samples 
were filtered under vacuum through glass-fibre 
filters (Whatman GF/B). To remove free and 
reversibly bound ligands, filters, kept on the filtra- 
tion manifold with the vacuum released, were in- 
cubated with 5 ml of buffer B at 37°C for 5 min 
after which the buffer was removed by vacuum ap- 
plication. This wash procedure was repeated four 
times in total. Then free receptor sites were deter- 
mined using a new filter assay procedure [ 1 l] with 
modifications. In short, filters positioned on the 
filtration manifold were incubated for 5 min with 
400~1 buffer B containing either 2 nM 
[3H]spiperone (for Sz-receptor assay) at 37°C or 
4 nM [3H]pyrilamine (for Hr-receptor assay) at 
25°C. Incubation was stopped by vacuum applica- 
tion and filters were rinsed twice with 5 ml of ice- 
cold buffer A. For the determination of non- 
specific binding, filters were incubated with the 
labelled ligand in the presence of 2pM 
methysergide or 1 PM astemizole for serotonin and 
histamine receptor determinations, respectively. 
The tissue, adsorbed to the filter, was found to re- 
tain its original receptor binding properties and 
serotonin-S2 or histamine-H* receptors were 
specifically labelled by the above-described filter 
assay procedure (unpublished). 
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3. RESULTS AND DISCUSSION 
The reversible binding of 7-azidoketanserin to 
histamine-H, receptors from guinea pig cerebellum 
was tested in competition binding experiments us- 
ing [3H]pyrilamine. The compound showed an 
ICsO value of 1.16 + 0.04 nM (mean f SE from 3 
experiments performed in triplicate). This value is 
much lower than that of the parent compound 
ketanserin, which has an 1% value of 18.6 nM. 
As previously reported, 7-azidoketanserin reveals 
an I&O value of 2.9 nM for inhibition of 
[3H]spiperone binding to serotonin-Sz receptors 
from rat pre-frontal cortex [9]. This makes the new 
azido compound almost equipotent in both recep- 
tor systems. 
Fig.2 shows the results of experiments in which 
membrane preparations of guinea pig cerebellum 
were preincubated with different concentrations of 
7-azidoketanserin and subsequently irradiated with 
UV light during 10 min. The amount of free 
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Fig.2. Effect of the concentration of 7-azidoketanserin 
on photolabelling of serotonin-Sz and histamine-H, 
receptors. Membrane preparations from rat pre-frontal 
cortex (Sz-receptors) or guinea pig cerebellum 
(HI-receptors) were preincubated with the indicated 
concentration of 7-azidoketanserin and subsequently 
photolysed for 10 min. Following photolysis the 
membranes were washed and remaining specific receptor 
binding was determined with [3H]spiperone or 
[3Hlpyrilamine, respectively. 
histamine-H, receptors decreased in a concen- 
tration-dependent manner with an apparent ICSO 
value of 12 nM. This is about two times higher 
than the value obtained for photolabelling of 
serotonin-S2 receptors in rat pre-frontal cortex 
(IGo = 5.60 nM) (fig.2). 
At all concentrations tested, the azide was 
shown to dissociate completely from the receptor 
when irradiation was omitted. At the highest con- 
centration used (lo-’ M) about 60 to 70% of 
specific binding to both histamine and serotonin 
receptors was irreversibly blocked. The fact that 
not all the receptors are photolabelled can be ex- 
plained in several different ways; possibly the azide 
functional group is not in a favourable position to 
undergo a covalent binding with the receptor pro- 
tein or the azide molecules bound to these recep- 
tors are shielded for the UV light and can therefore 
not be photolyzed. 
In experiments, similar to those described 
above, 7-azidoketanserin was also tested for pho- 
toinactivation of al-adrenergic receptors from rat 
forebrain. In this receptor model irreversible inac- 
tivation was seen only at higher micromolar con- 
centrations. Therefore, at nanomolar concentra- 
tions, used to photoinactivate serotonin-Sz and 
histamine-H1 receptors, no interference by binding 
to crl-adrenergic receptors is to be expected. 
To make sure that excess azide could eventually 
be washed out before photolysis, experiments were 
performed in which membranes were preincubated 
with 10 nM 7_azidoketanserin, subsequently 
washed by centrifugation and then submitted to 
UV irradiation and binding assay. In these ex- 
periments, the same extent of photoinactivation 
was obtained as in the experiments described 
above. 
Fig.3 shows the time-dependence of the 
photolysis reaction of 7-azidoketanserin on both 
serotonin and histamine receptors. Membrane 
preparations were preincubated with lo-’ M 7-azi- 
doketanserin and subsequently photolyzed during 
different periods of time. Irreversible blocking of 
both receptors was rapid, reaching a plateau value 
after about 5 min. When membranes were prein- 
cubated with the solvent alone and then irradiated, 
no decrease of specific binding was seen, indicating 
that UV irradiation alone did not affect the recep- 
tor systems. 
Several compounds were tested for their ability 
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Fig.3. Effect of the time of irradiation on photolabelling of serotonin-Sz and histamine-H, receptors. Membrane 
preparations of rat pre-frontal cortex (&-receptors) (A) or guinea pig cerebellum (HI-receptors) (B) were preincubated 
with lo-’ M 7-azidoketanserin (-) or the solvent (---) and subsequently irradiated for the indicated periods of 
time. Following photolysis, the membranes were washed and remaining specific receptor binding was determined with 
[3H]spiperone or [3H]pyrilamine, respectively. 
to inhibit photolabelling of histamine-HI receptors 
in guinea pig cerebellum. Aliquots of the mem- 
brane suspension were incubated with 10 nM 
7-azidoketanserin and increasing concentrations of 
the compounds. Following irradiation for 10 min 
they were washed and assayed for [3H]pyrilamine 
binding. Table 1 summarizes the results expressed 
as ICSO values for inhibition of photolabelling. 
They are compared to the I&J values, obtained for 
inhibition of photolabelling of serotonin-S2 recep- 
tors from rat pre-frontal cortex. Potent histamine 
antagonists such as chlorpheniramine and 
pyrilamine used at nanomolar concentrations were 
able to protect Ht-receptors against photolabel- 
ling. Histamine itself showed inhibition at high 
micromolar concentrations which corresponds to 
the potency of this neurotransmitter for binding to 
histamine-HI receptors. Serotonin antagonists 
(pipamperone and droperidol) and agonists 
(bufotenine and serotonin) did not show any in- 
hibitory effect; neither did haloperidol (a 
dopamine antagonist), 2-(N,N-dipropyl)-amino- 
5,6_dihydroxytetralin (a dopamine agonist) nor 
WB 4101 (an at-adrenergic antagonist). 
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Apart from histamine-HI receptors, the guinea 
pig cerebellum also contains a small amount of 
[3H]spiperone binding sites (fig.4A). These sites 
could be blocked completely by the addition of 
lo-’ M pipamperone, a selective &-antagonist. At 
this concentration, pipamperone had no effect at 
all on both reversible [3H]pyrilamine binding [12] 
and photolabelling of the histamine receptors. In 
the same way, [3H]pyrilamine binding sites in rat 
pre-frontal cortex could be blocked completely 
with lo-’ M pyrilamine (fig.4B) and this had no 
effect on reversible [3H]spiperone binding [2] and 
photolabelling of serotonin receptors. This pro- 
vides a way for differential photolabelling of either 
of both receptor types. 
The foregoing results demonstrate that: (i) 
7-azidoketanserin has an equally high affinity for 
binding to histamine-HI receptors and serotonin- 
Sz receptors; (ii) after preincubation with 
7-azidoketanserin and UV irradiation, Ht-recep- 
tors become irreversibly blocked; (iii) this irrever- 
sible binding can be inhibited by histamine antago- 
nists and histamine itself but not by compounds 
with other pharmacological activities; (iv) the 
Volume 182, number 2 FEBS LETTERS March 1985 
Table 1 
Inhibition by various compounds of photolabelling of 
histamine-f-l) receptors and serotonin-Sz receptors with 
7azidoketanserin 
Compound IGO (nW 
Histamine-Hi” Serotonin-Sxb 
receptors receptors 
Chlorphenir~mine 4.0 >lOOO 
Pyrilamine 19.9 > 1000 
Pipamperone > 1000 12.6 
Droperidol > 1000 25.1 
Ketanserin 31.6 11.2 
Histamine 8900 > 10000 
Bufotenine > 10000 1122 
Serotonin > 10000 10000 
Haloperidol >lOOO >lOOO 
2-(N,N-Dipropyl)- 
amino-5,6-di- 
hydroxytetralin > 10000 >lOOOO 
WB 4101 >lOOO >lOOO 
- 
a Aliquots of guinea pig cerebellum membrane prepra- 
tions were incubated with IO nM 7azidoketanserin in 
the presence of increasing concentrations of the test 
compounds. Following photolysis for 10 min, the 
samples were washed and assayed for [3H]pyrilamine 
binding as described in the text. The ICSO value is the 
concentration of the compound, needed to reduce 
photolabelling to 50%. Percentage photolabelling was 
calculated as: (Bi - B&‘(B3 - Bz) where Br = binding 
after photolysis in the presence of azide and the test 
compound; BZ = binding after photolysis in the 
presence of azide alone; and B3 = binding after 
photolysis in the presence of the test compound alone 
b Values taken from [9] 
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Fig.4. Differential photolabelling of serotonin-Sa receptors and histamine-Hi receptors. (A) Guinea pig cerebelfum: 
[‘Hlpyrilamine binding (shaded areas) and photolabelling in the presence of lo-* M 7-azidoketanserin (blank areas) of 
HI-receptors and [3H]spiperone binding to &-receptors in the presence (+) or the absence (- ) of IO-’ M pipamperone 
(the total amount of $-sites was calculated as a percentage of the total mount of Hi-sites). (B) Rat pre-frontal cortex: 
[3H]spiperone binding (shaded areas) and photolabelling in the presence of lo-* M “I-azidoketanserin (blank areas) of 
&-receptors and [3H]pyrilamine binding to Hr-receptors from rat pre-frontal cortex in the presence (+) or the absence 
(-) of IO-’ M pyrilamine (the total amount of Hi-sites was calculated as a percentage of the total amount of &-sites). 
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photolabelling reaction with 7-azidoketanserin can 
be directed exclusively to either HI- or S2-receptors 
using a highly enriched tissue (guinea pig cerebel- 
lum for HI-receptors; rat pre-frontal cortex fr 
Sz-receptors) and by blocking remaining unwanted 
receptors with a high concentration of either 
pipamperone or pyrilamine. Therefore, radioac- 
tively labelled 7-azidoketanserin, which is present- 
ly being synthesized, should provide a powerful 
tool for the elucidation of the molecular structure 
of both serotonin-S2 and histamine-HI receptors. 
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